VISTN Share Price Performance
NOK 19.30
-4.50 (-18.91%)
Price NOK 19.30
Share Pricen/a
Vistin Pharma ASA Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
VISTN Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Vistin Pharma ASA Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Oct 29, 2026
- 1.58
- 67.61%
- 16.25%
- 4.8%
About VISTN
- Founded
- 1969
- Employees
- 76
- CEO
- WebsiteView website
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) in Africa, Europe, Asia, and North and South America. It offers metformin HCl; metformin direct compressible; and metformin premixed with lubricant magnesium stearate for use in plain metformin immediate release tablets. The company was founded in 1969 and is based in Oslo, Norway.
